Agios Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 40.62. In total, the insiders bought 743 629 and sold 256 373 AGIO shares in the last 100 trades.

Insider Power

(Last 100 transactions)
40.62
Buy 743 629 Shares
Sell 256 373 Shares

Historical Insider Trades

Date Type Action Person Amount
Nov 08, 2024 Common stock Sell Washburn Theodore James Jr. 772
Nov 08, 2024 Common stock Buy Ballal Rahul D. 10 000
Nov 08, 2024 Stock option (right to buy) Sell Ballal Rahul D. 10 000
Nov 08, 2024 Common stock Sell Ballal Rahul D. 3 571
Nov 08, 2024 Common stock Sell Ballal Rahul D. 4 929
Nov 08, 2024 Common stock Sell Ballal Rahul D. 1 500
Nov 07, 2024 Stock option (right to buy) Sell Ballal Rahul D. 10 000
Nov 07, 2024 Common stock Sell Ballal Rahul D. 8 132
Nov 07, 2024 Common stock Sell Ballal Rahul D. 1 868
Nov 07, 2024 Common stock Sell Burns James William 13 411
Nov 07, 2024 Common stock Sell Burns James William 8 341
Sep 26, 2024 Common stock Buy Jones Cecilia 7 473
Sep 26, 2024 Common stock Sell Jones Cecilia 2 542
Sep 26, 2024 Restricted stock units Sell Jones Cecilia 7 473
Aug 11, 2024 Common stock Buy Ballal Rahul D. 2 302
Aug 11, 2024 Restricted stock units Sell Ballal Rahul D. 2 302
Aug 11, 2024 Common stock Buy Smith Cynthia 2 302
Aug 11, 2024 Restricted stock units Sell Smith Cynthia 2 302
Aug 08, 2024 Common stock Buy Goff Brian 22 691
Aug 08, 2024 Common stock Sell Goff Brian 11 091
Aug 08, 2024 Restricted stock units Sell Goff Brian 22 691
Jul 01, 2024 Common stock Buy Gheuens Sarah 8 375
Jul 01, 2024 Common stock Sell Gheuens Sarah 3 705
Jul 01, 2024 Restricted stock units Sell Gheuens Sarah 8 375
Jun 20, 2024 Stock options (right to buy) Buy Fouse Jacqualyn A 11 774
Click to get the best stock tips daily for free!
ABOUT AGIOS PHARMACEUTICALS
Agios Pharmaceuticals
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Ph...
GOLDEN STAR
Ticker Change Signal Date
SMAR
$56.02
0.196% Dec 03
G
GOF
$15.83
0.790% Dec 02
QSR
$69.61
0.165% Nov 29
HP
$34.63
0.462% Nov 29
B
BSCO
$21.11
0.0947% Nov 27

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE